BOIRF
Price
$24.30
Change
+$0.30 (+1.25%)
Updated
Aug 14 closing price
Capitalization
434.15M
ELAN
Price
$17.96
Change
-$0.04 (-0.22%)
Updated
Aug 15 closing price
Capitalization
8.92B
87 days until earnings call
Interact to see
Advertisement

BOIRF vs ELAN

Header iconBOIRF vs ELAN Comparison
Open Charts BOIRF vs ELANBanner chart's image
Boiron
Price$24.30
Change+$0.30 (+1.25%)
Volume$300
Capitalization434.15M
Elanco Animal Health
Price$17.96
Change-$0.04 (-0.22%)
Volume$6.85M
Capitalization8.92B
BOIRF vs ELAN Comparison Chart in %
Loading...
BOIRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BOIRF vs. ELAN commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOIRF is a Hold and ELAN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (BOIRF: $24.30 vs. ELAN: $17.96)
Brand notoriety: BOIRF: Not notable vs. ELAN: Notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BOIRF: 142% vs. ELAN: 125%
Market capitalization -- BOIRF: $434.15M vs. ELAN: $8.92B
BOIRF [@Pharmaceuticals: Generic] is valued at $434.15M. ELAN’s [@Pharmaceuticals: Generic] market capitalization is $8.92B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOIRF’s FA Score shows that 2 FA rating(s) are green whileELAN’s FA Score has 0 green FA rating(s).

  • BOIRF’s FA Score: 2 green, 3 red.
  • ELAN’s FA Score: 0 green, 5 red.
According to our system of comparison, BOIRF is a better buy in the long-term than ELAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOIRF’s TA Score shows that 0 TA indicator(s) are bullish while ELAN’s TA Score has 5 bullish TA indicator(s).

  • BOIRF’s TA Score: 0 bullish, 4 bearish.
  • ELAN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ELAN is a better buy in the short-term than BOIRF.

Price Growth

BOIRF (@Pharmaceuticals: Generic) experienced а +1.25% price change this week, while ELAN (@Pharmaceuticals: Generic) price change was +7.74% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +4.25%. For the same industry, the average monthly price growth was +10.98%, and the average quarterly price growth was +78.05%.

Reported Earning Dates

ELAN is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+4.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELAN($8.92B) has a higher market cap than BOIRF($434M). BOIRF has higher P/E ratio than ELAN: BOIRF (31.92) vs ELAN (20.41). ELAN YTD gains are higher at: 48.307 vs. BOIRF (-14.737).
BOIRFELANBOIRF / ELAN
Capitalization434M8.92B5%
EBITDAN/A1.4B-
Gain YTD-14.73748.307-31%
P/E Ratio31.9220.41156%
RevenueN/A4.43B-
Total CashN/A487M-
Total DebtN/A4.4B-
FUNDAMENTALS RATINGS
BOIRF vs ELAN: Fundamental Ratings
BOIRF
ELAN
OUTLOOK RATING
1..100
9520
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
93
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
6880
PRICE GROWTH RATING
1..100
8538
P/E GROWTH RATING
1..100
993
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BOIRF's Valuation (7) in the null industry is significantly better than the same rating for ELAN (93) in the Agricultural Commodities Or Milling industry. This means that BOIRF’s stock grew significantly faster than ELAN’s over the last 12 months.

BOIRF's Profit vs Risk Rating (100) in the null industry is in the same range as ELAN (100) in the Agricultural Commodities Or Milling industry. This means that BOIRF’s stock grew similarly to ELAN’s over the last 12 months.

BOIRF's SMR Rating (68) in the null industry is in the same range as ELAN (80) in the Agricultural Commodities Or Milling industry. This means that BOIRF’s stock grew similarly to ELAN’s over the last 12 months.

ELAN's Price Growth Rating (38) in the Agricultural Commodities Or Milling industry is somewhat better than the same rating for BOIRF (85) in the null industry. This means that ELAN’s stock grew somewhat faster than BOIRF’s over the last 12 months.

BOIRF's P/E Growth Rating (9) in the null industry is significantly better than the same rating for ELAN (93) in the Agricultural Commodities Or Milling industry. This means that BOIRF’s stock grew significantly faster than ELAN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BOIRFELAN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
73%
Stochastic
ODDS (%)
N/A
Bearish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
41%
Bullish Trend 2 days ago
55%
MACD
ODDS (%)
Bearish Trend 2 days ago
36%
Bullish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
11%
Bullish Trend 2 days ago
66%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
29%
Bullish Trend 2 days ago
65%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
62%
Declines
ODDS (%)
N/A
Bearish Trend 17 days ago
73%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
BOIRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DILYX15.260.05
+0.33%
Davis International Y
GRMAX30.09N/A
N/A
Nationwide S&P 500 Index A
KTRCX9.40N/A
N/A
DWS Global Income Builder C
MRGBX44.64-0.16
-0.36%
MFS Core Equity B
APDWX10.81-0.04
-0.37%
Artisan Value Income Advisor

BOIRF and

Correlation & Price change

A.I.dvisor tells us that BOIRF and ELAN have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BOIRF and ELAN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOIRF
1D Price
Change %
BOIRF100%
N/A
ELAN - BOIRF
21%
Poorly correlated
-0.22%
BUDZ - BOIRF
7%
Poorly correlated
-13.11%
BSPK - BOIRF
4%
Poorly correlated
N/A
APNHY - BOIRF
3%
Poorly correlated
N/A
BIOVF - BOIRF
1%
Poorly correlated
N/A
More

ELAN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELAN has been loosely correlated with VTRS. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ELAN jumps, then VTRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAN
1D Price
Change %
ELAN100%
-0.22%
VTRS - ELAN
47%
Loosely correlated
-0.75%
ZTS - ELAN
46%
Loosely correlated
+0.69%
PAHC - ELAN
40%
Loosely correlated
+0.33%
SNDL - ELAN
39%
Loosely correlated
-4.27%
TLRY - ELAN
36%
Loosely correlated
-12.71%
More